McKinley Capital Management’s bluebird bio BLUE Stock Holding History

McKinley Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-309	Closed	-$351K	–	189
2019 Q4	$351K	Buy	+309	New	+$336K	0.02%	182
2019 Q2	–	Sell	-207	Closed	-$421K	–	219
2019 Q1	$421K	Buy	207 +135	+188%	+$238K	0.03%	163
2018 Q4	$92K	Sell	72 -94	-57%	-$144K	0.01%	196
2018 Q3	$313K	Sell	166 -4	-2%	-$8.26K	0.02%	174
2018 Q2	$345K	Sell	170 -13	-7%	-$29.6K	0.02%	174
2018 Q1	$404K	Sell	183 -533	-74%	-$1.36M	0.02%	174
2017 Q4	$1.65M	Buy	716 +552	+337%	+$1.12M	0.08%	174
2017 Q3	$292K	Buy	+164	New	+$229K	0.01%	288

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

McKinley Capital Management's BLUE Position: Q1 2020 in Review

McKinley Capital Management sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 309 shares — an estimated $351K sold.

McKinley Capital Management first reported a position in BLUE in Q3 2017 and held it in 8 quarters. The position peaked at $1.65M in Q4 2017. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

McKinley Capital Management reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
McKinley Capital Management sold 309 bluebird bio shares in Q1 2020, an estimated $351K.
McKinley Capital Management first reported a position in bluebird bio in Q3 2017 and held it in 8 quarters.
McKinley Capital Management's bluebird bio position peaked at $1.65M in Q4 2017.
247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on McKinley Capital Management's 13F filing for Q1 2020, filed 5 May 2020.